Amedeo Smart

Free Medical Literature Service


 

Amedeo

Diabetes

  Free Subscription

04.05.2025

2 Am J Kidney Dis
2 Am J Ophthalmol
3 BMC Ophthalmol
1 BMC Pediatr
1 BMJ
2 Circulation
6 Diabet Med
1 Diabetes
2 Diabetes Care
6 Diabetes Obes Metab
4 Diabetologia
2 J Clin Endocrinol Metab
1 J Clin Invest
4 J Diabetes Complications
1 J Immunol
1 JAMA
1 Ophthalmol Retina
86 Pediatr Diabetes
1 PLoS Med
1 PLoS One
1 Stroke



    Am J Kidney Dis

  1. LEE YC, Wu LC, Wu VC, Chang CH, et al
    Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists and Sodium/Glucose Cotransporter 2 Inhibitors in Preventing Chronic Kidney Failure and Mortality in Patients With Type 2 Diabetes and CKD.
    Am J Kidney Dis. 2025 Apr 29:S0272-6386(25)00831.
    >> Share

  2. KANG MW, Oh JI, Lee J, Kim M, et al
    Longitudinal Income Dynamics and Risk of End-Stage Kidney Disease in Type 2 Diabetes: A South Korean Population-Based Cohort Study.
    Am J Kidney Dis. 2025 Apr 23:S0272-6386(25)00825.
    >> Share


    Am J Ophthalmol

  3. WANG Z, Yu Y, Ye Y, Wang L, et al
    Associations between Ambient Air Pollution and Five Common Vision-threatening Ocular Diseases in Middle-aged and Older Adults: A Large Prospective Cohort Study.
    Am J Ophthalmol. 2025 Mar 6:S0002-9394(25)00121.
    >> Share

  4. ABBASS NJ, Nahlawi R, Shaia JK, Allan KC, et al
    The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy.
    Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00094.
    >> Share


    BMC Ophthalmol

  5. HARLEY O, Amelia YS, Gustianty E, Soetedjo NNM, et al
    Exploring leukocyte differential count ratio profiles as inflammatory biomarkers in diabetic retinopathy: a systematic review and meta-analysis.
    BMC Ophthalmol. 2025;25:265.
    >> Share

  6. ZHOU J, Wang X, Lou W, Li T, et al
    Peripapillary Bruch's membrane Opening-Minimum Rim Width (BMO-MRW) and microvascular changes in early diabetic retinopathy.
    BMC Ophthalmol. 2025;25:257.
    >> Share

  7. YI G, Yu H
    Risk factors for pupil changes in patients with diabetic retinopathy and cataract after phacoemulsification with intraocular lens implantation.
    BMC Ophthalmol. 2025;25:252.
    >> Share


    BMC Pediatr

  8. J COCKCROFT E, Chithuranjan D, Narendran P, C Andrews R, et al
    Quality of life and physical activity in type 1 diabetes.
    BMC Pediatr. 2025;25:345.
    >> Share


    BMJ


  9. Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study.
    BMJ. 2025;389:r845.
    >> Share


    Circulation

  10. DONG J, Yang X, Zhang W
    Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e962-e963.
    >> Share

  11. BONNESEN K, Heide-Jorgensen U, Schmidt M
    Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
    Circulation. 2025;151:e964.
    >> Share


    Diabet Med

  12. BADDOCK S, Raven L, Abeygunasekara G, Roche M, et al
    Management of diabetic ketoacidosis in adult inpatients: A retrospective analysis of rates of hypoglycaemia with variable-rate and fixed-rate intravenous insulin infusion protocols.
    Diabet Med. 2025 May 1:e70063. doi: 10.1111/dme.70063.
    >> Share

  13. HEALD AH, Stedman M, Jude E, Habte-Asres H, et al
    Does glycaemic control or renal function provide a better indicator for the service support required in type 1 diabetes?
    Diabet Med. 2025 May 1:e70050. doi: 10.1111/dme.70050.
    >> Share

  14. SHAH MU, Cliff CL, Squires PE, Lee K, et al
    The cardio-renal-metabolic role of the nod-like receptor protein-3 and senescence-associated secretory phenotype in early sodium/glucose cotransporter-2 inhibitor therapy in people with diabetes who have had a myocardial infarction.
    Diabet Med. 2025 Apr 25:e70059. doi: 10.1111/dme.70059.
    >> Share

  15. SANKARESWARAN A, Kunte P, Fraser DP, Shaik M, et al
    HLA haplotype diversity, islet autoantibody status and discriminative ability of type 1 diabetes genetic risk score in Indians.
    Diabet Med. 2025 Apr 25:e70041. doi: 10.1111/dme.70041.
    >> Share

  16. RAMA CHANDRAN S, Choo KJL, Tan HC, Zin Oo M, et al
    Skin reactions to Freestyle Libre Pro among individuals with and without diabetes.
    Diabet Med. 2025 Apr 25:e70062. doi: 10.1111/dme.70062.
    >> Share

  17. DLUGATCH R, Rankin D, Evans M, Oliver N, et al
    Improving access to diabetes technologies in children and young people with type 1 diabetes: Healthcare professionals' perspectives and views.
    Diabet Med. 2025 Apr 25:e70058. doi: 10.1111/dme.70058.
    >> Share


    Diabetes


  18. A Special Thanks to the Reviewers of Diabetes.
    Diabetes. 2025;74:454.
    >> Share


    Diabetes Care

  19. SHAWA H, Kaur R, Tchanque-Fossuo C, Lev-Tov H, et al
    Cellular Versus Acellular Matrix Products for Diabetic Foot Ulcer Treatment: The Dermagraft and Oasis Longitudinal Comparative Efficacy Study (DOLCE)-A Randomized Clinical Trial.
    Diabetes Care. 2025 Apr 29:dc241233. doi: 10.2337/dc24-1233.
    >> Share

  20. ARODA VR, Jorgensen NB, Kumar B, Lingvay I, et al
    High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial.
    Diabetes Care. 2025 Apr 25:dc242425. doi: 10.2337/dc24-2425.
    >> Share


    Diabetes Obes Metab

  21. YU N, Xu W, Guo X, Xu M, et al
    Fotagliptin add-on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
    Diabetes Obes Metab. 2025 Apr 30. doi: 10.1111/dom.16427.
    >> Share

  22. KHODABANDEHLOO P, Fakembe P, Senga J, Shulman R, et al
    Social disadvantage and technology use among adults with type 1 diabetes in Quebec: A cross-sectional study using data from the Canadian T1D (BETTER) Registry.
    Diabetes Obes Metab. 2025 Apr 29. doi: 10.1111/dom.16426.
    >> Share

  23. FIELD BCT
    The BIG D-FOOT randomized, double-blinded, controlled trial of bio-absorbable antibiotic delivery in calcium sulphate granules for the treatment of diabetic foot osteomyelitis.
    Diabetes Obes Metab. 2025 Apr 29. doi: 10.1111/dom.16423.
    >> Share

  24. MONAMI M, Mannucci E
    Reply to Dr. Field on 'The BIG D-FOOT randomized, double-blinded, controlled trial of bio-absorbable antibiotic delivery in calcium sulphate granules for the treatment of diabetic foot osteomyelitis'.
    Diabetes Obes Metab. 2025 Apr 29. doi: 10.1111/dom.16428.
    >> Share

  25. HE J
    Remnant cholesterol trajectories and diabetes risk: A letter to the editor commenting on "Changes in remnant cholesterol and the incidence of diabetes: Results from two large prospective cohort studies".
    Diabetes Obes Metab. 2025 Apr 28. doi: 10.1111/dom.16430.
    >> Share

  26. SNOEK F, Galstyan G, Khan N, Tirosh A, et al
    Clinically meaningful improvements in treatment satisfaction in insulin-naive people with type 2 diabetes post initiation of insulin glargine 300 U/mL: A post hoc analysis of real-world ATOS study.
    Diabetes Obes Metab. 2025 Apr 28. doi: 10.1111/dom.16415.
    >> Share


    Diabetologia

  27. SAGAR RC, Yates DM, Pearson SM, Kietsiriroje N, et al
    Insulin resistance in type 1 diabetes is a key modulator of platelet hyperreactivity.
    Diabetologia. 2025 Apr 30. doi: 10.1007/s00125-025-06429.
    >> Share

  28. ADESHARA K, Parente EB, Harjutsalo V, Lehto M, et al
    Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years.
    Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06440.
    >> Share

  29. PURVIS GSD, Chiazza F, Chen J, Azevedo-Loiola R, et al
    Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.
    Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06418.
    >> Share

  30. LEWIS CTA, Moreno-Justicia R, Savoure L, Calvo E, et al
    Dysregulated skeletal muscle myosin super-relaxation and energetics in male participants with type 2 diabetes mellitus.
    Diabetologia. 2025 Apr 28. doi: 10.1007/s00125-025-06436.
    >> Share


    J Clin Endocrinol Metab

  31. WANG L, Lin H, Zhao Z, Chen L, et al
    Regional Brain Structure Alterations in Diabetes but Not Prediabetes: the Shanghai Changfeng Study.
    J Clin Endocrinol Metab. 2025 Apr 30:dgaf248. doi: 10.1210.
    >> Share

  32. GOEDECKE JH, Kufe CN, Masemola M, Lichaba M, et al
    SHBG, testosterone and type 2 diabetes risk in middle-aged African women: exploring the impact of HIV and menopause.
    J Clin Endocrinol Metab. 2025 Apr 28:dgaf256. doi: 10.1210.
    >> Share


    J Clin Invest

  33. PETRIE GN, Mayo LM
    GLP-1 receptor agonists for the treatment of alcohol use disorder.
    J Clin Invest. 2025;135:e192414.
    >> Share


    J Diabetes Complications

  34. BARBARESKO J, Lang A, Schiemann TB, Schaefer E, et al
    Dietary factors and cancer outcomes in individuals with type 2 diabetes: A systematic review and meta-analysis of prospective observational studies.
    J Diabetes Complications. 2025;39:109060.
    >> Share

  35. PENNISI G, Petta S, Maggio V, Rizzo M, et al
    GLP-1 receptor agonists and MASLD in diabetes: A promising path?
    J Diabetes Complications. 2025 Apr 22:109041.
    >> Share

  36. SOLTANI P, Almeida FM, Melo HCC, Ferreira GBS, et al
    Body-weight functional exercise promotes greater and safer blood glucose reduction compared to aerobic and strength exercises in type 1 diabetics: a randomised crossover study.
    J Diabetes Complications. 2025;39:109043.
    >> Share

  37. COLACCI M, Raudanskis A, Fralick M
    Response to letter to the editor by Lai-Ming Kathleen Pak et al on: Identifying predictors of SGLT2 inhibitor and GLP1R agonist use in hospital among adults with diabetes.
    J Diabetes Complications. 2025 Apr 23:109046.
    >> Share


    J Immunol

  38. TURICEK DP, Wan X
    Decoding autoimmunity: HLA-DQbeta and type 1 diabetes.
    J Immunol. 2025 Apr 28:vkaf070. doi: 10.1093.
    >> Share


    JAMA

  39. ANDERER S
    Tirzepatide Outperforms Dulaglutide for Type 2 Diabetes Control.
    JAMA. 2025 May 2. doi: 10.1001/jama.2025.5645.
    >> Share


    Ophthalmol Retina

  40. TAN TE, Ng YP, Calhoun C, Chaung JQ, et al
    Detection of Center-Involved Diabetic Macular Edema with Visual Impairment using Multimodal Artificial Intelligence Algorithms.
    Ophthalmol Retina. 2025 Apr 24:S2468-6530(25)00173.
    >> Share


    Pediatr Diabetes

  41. RUIZ-ARANDA D, Luque A, Russo F, Fenollar-Cortes J, et al
    Sociocultural Attitudes Toward Appearance and Attitudes Toward Eating in Adolescents With Type 1 Diabetes: The Importance of Perfectionism.
    Pediatr Diabetes. 2025;2025:9993342.
    >> Share

  42. DING Y, Zhang Q, Gao S, Li J, et al
    Focusing on Rare Variants Related to Maturity-Onset Diabetes of the Young in Children.
    Pediatr Diabetes. 2025;2025:8155443.
    >> Share

  43. PAMIDIMUKKALA K, Ferm ML, Erraguntla M, Haridas B, et al
    Real-World Insights Into Hypoglycemia Risk While Driving in Teens and Young Adults With Type 1 Diabetes.
    Pediatr Diabetes. 2025;2025:5053872.
    >> Share

  44. CHOE A, Fredericks EM, Albright D, Lee JM, et al
    Executive Functioning, Diabetes Distress, and Diabetes Management Among Adolescents With Type 1 Diabetes: Youth and Parent Perspectives.
    Pediatr Diabetes. 2025;2025:7036544.
    >> Share

  45. NUKPEZAH RN, Tsigbe CC
    Transition of Adolescents With Diabetes Mellitus to Adult Care at the Ho Teaching Hospital in Ghana.
    Pediatr Diabetes. 2025;2025:7577764.
    >> Share

  46. MCMANUS L, Vinson C, Patel D, Faichtinger C, et al
    Positive Impact of a Specialized Summer Camp on the Correlation Between Improved Mental Health and Glycemic Control in Pediatric Type 1 Diabetic Patients.
    Pediatr Diabetes. 2025;2025:4811222.
    >> Share

  47. SPAJIC D, Curran J, Luu Y, Shah MAE, et al
    Diabetes Distress and Unmet Support Needs Hinder Optimal Care for Adolescents With Type 2 Diabetes: A Mixed Methods Study.
    Pediatr Diabetes. 2025;2025:5574666.
    >> Share

  48. VONASEK J, Larsen IM, Nikontovic A, Thorvig CM, et al
    A Novel Follow-Up Model for Type 1 Diabetes in Children Leads to Higher Glycemic Control.
    Pediatr Diabetes. 2025;2025:6920068.
    >> Share

  49. SADDER F, Nemer M
    Assessment of Health-Related Quality of Life Among Palestinian Adolescents With Type 1 Diabetes: A Cross-Sectional Investigation.
    Pediatr Diabetes. 2025;2025:3568243.
    >> Share

  50. HAWKE K, Ng SZ, Anderson J, Dharmaputra R, et al
    Diabetes Complications among Inpatients with Childhood and Young Adult-Onset Type 1 and 2 Diabetes.
    Pediatr Diabetes. 2024;2024:9926090.
    >> Share

  51. BELL RA, Rigdon J, Bellatorre A, Dabelea D, et al
    Trends in CVD Risk Factors for Youth with Incident Diabetes: SEARCH for Diabetes in Youth.
    Pediatr Diabetes. 2024;2024:5213520.
    >> Share

  52. GOLDSTEIN S, Chow O, Schwartz J, Pais V, et al
    Assessing the Feasibility and Acceptability of a Virtual Food Skills and Food Sustainability Program Designed for Children Living With Type 1 Diabetes.
    Pediatr Diabetes. 2024;2024:3821265.
    >> Share

  53. AL-GADI IS, Albalawi AD, Al Khalifah RA
    The Psychometric Properties of the Type 1 Diabetes Mellitus Screening Acceptability Assessment (DMSA) Scale among General Population.
    Pediatr Diabetes. 2024;2024:1286029.
    >> Share

  54. TRIOLO TM, Jacobsen LM, Cuthbertson D, Sims EK, et al
    Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes.
    Pediatr Diabetes. 2024;2024:8343868.
    >> Share

  55. ROBERTS A, Dart J, Lloyd S, Bebbington K, et al
    "I Think I Could Have Used It Better": Experiences of Youth with High HbA1c Commencing Advanced Hybrid Closed-Loop Therapy in a Clinical Trial Setting-A Qualitative Research.
    Pediatr Diabetes. 2024;2024:6260002.
    >> Share

  56. RUIZ-GRAO MC, Diez-Fernandez A, Mesas AE, Martinez-Vizcaino V, et al
    Trends in the Incidence of Type 1 Diabetes in European Children and Adolescents from 1994 to 2022: A Systematic Review and Meta-Analysis.
    Pediatr Diabetes. 2024;2024:2338922.
    >> Share

  57. DOS SANTOS BORGES R, Conegundes AF, Haikal de Paula L, Lara Santos R, et al
    Efficacy and Safety of SGLT2 Inhibitors in Pediatric Patients and Young Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Pediatr Diabetes. 2024;2024:6295345.
    >> Share

  58. WINTER T, Derraik JGB, Jefferies CA, Hofman PL, et al
    Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand.
    Pediatr Diabetes. 2024;2024:5893771.
    >> Share

  59. LIEU F, Martin WN, Birt S, Mattes J, et al
    Development of a Multivariable Risk Prediction Tool to Predict Adverse Outcomes among Children with Type 1 Diabetes: A Pilot Study.
    Pediatr Diabetes. 2024;2024:8335604.
    >> Share

  60. ALJOHANI N, Donetto S, Due-Christensen M, Forbes A, et al
    The Journey to Adulthood: A Systematic Review of Interventions in Type 1 Diabetes Paediatric to Adult Transition Care.
    Pediatr Diabetes. 2024;2024:1773726.
    >> Share

  61. MORARD I, Barat P, Bailhache M
    Associations of Area-Level and Parental Individual-Level Social Deprivation with Glycemic Control over Time among Children with Type 1 Diabetes in France: A Longitudinal Cohort Study.
    Pediatr Diabetes. 2024;2024:9634867.
    >> Share

  62. REN L, Yang J, Wu L, Gao Y, et al
    Capillary Glycated Hemoglobin A1c Percentiles and the Risk Factors Associated with Abnormal HbA1c among Chinese Children Aged 3-12 Years.
    Pediatr Diabetes. 2024;2024:8333590.
    >> Share

  63. ASAAD M, Abu Ghazaleh H, Tzouvara V, Zhao X, et al
    Psychosocial-Spiritual Experiences and Outcomes in Parents of Children with Type 1 Diabetes Mellitus from the Middle East and North Africa Region: A Systematic Review.
    Pediatr Diabetes. 2024;2024:6111661.
    >> Share

  64. EL-DASSOUKI N, Taylor M, Pfisterer KJ, Saragadam A, et al
    Supporting Adolescents and Young Adults through Digitally Mediated Type 1 Diabetes Transition Care: A Qualitative Descriptive Study.
    Pediatr Diabetes. 2024;2024:3721768.
    >> Share

  65. LUO Y, Luo D, Li M, Tang B, et al
    Insulin Resistance in Pediatric Obesity: From Mechanisms to Treatment Strategies.
    Pediatr Diabetes. 2024;2024:2298306.
    >> Share

  66. TELLEZ S, Hornung L, Smith E, Trout A, et al
    Real-World Accuracy of a Continuous Glucose Monitoring System after Radiologic Exposure.
    Pediatr Diabetes. 2024;2024:2210509.
    >> Share

  67. MCCULLOUGH ME, Letourneau-Freiberg LR, Bowden TL, Kandasamy B, et al
    Clinical Characteristics and Remission Monitoring of 6q24-Related Transient Neonatal Diabetes.
    Pediatr Diabetes. 2024;2024:3624339.
    >> Share

  68. POON MS, Chan AKF, Cusumano JM, Craig ME, et al
    Complications during Adolescence Predict Mortality in Young Adults with Childhood Onset Type 1 Diabetes.
    Pediatr Diabetes. 2024;2024:8194756.
    >> Share

  69. CHENOWETH DJ, Palmer BA, Norris AW, Tansey MJ, et al
    Adolescent-Initiated Retrospective Glucose Data Review is Associated With Improved Glycemia in Type 1 Diabetes Mellitus.
    Pediatr Diabetes. 2024;2024:5218915.
    >> Share

  70. COCKCROFT EJ, Clarke R, Dias RP, Lloyd J, et al
    Effectiveness of Educational and Psychoeducational Self-Management Interventions in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-Analysis.
    Pediatr Diabetes. 2024;2024:2921845.
    >> Share

  71. DAMM JA, Dalgas-Madsen A, Bech AMK, Pilgaard KA, et al
    Associations Between Arterial Stiffness and Metabolic Target in Children and Adolescents With Type 1 Diabetes Treated in a Modern Setting.
    Pediatr Diabetes. 2024;2024:5528717.
    >> Share

  72. CARVALHO-RIBEIRO IA, Cunha LCF, Ribeiro LR, Lima MN, et al
    Adolescents and Young Adults with Type 1 Diabetes Present Changes in Arterial Compliance and Resistance and Increased Arterial Stiffness.
    Pediatr Diabetes. 2024;2024:9919121.
    >> Share

  73. LAIN SJ, Stevens L, Craig ME, Jenkins AJ, et al
    Excess Mortality in an Inception Cohort of Childhood Diabetes Diagnosed 1990-2010.
    Pediatr Diabetes. 2024;2024:1844752.
    >> Share

  74. THAKKAR A, Huang X, Wang J, Hwu K, et al
    Elevated Serum IgA at Onset of Type 1 Diabetes in Children.
    Pediatr Diabetes. 2024;2024:7284088.
    >> Share

  75. HUANG F, Lin Z, Lu Y, Zhou Y, et al
    The Prevalence and Associated Factors of Impaired Fasting Glucose among Children and Adolescents in Urban China: A Large-Scale Cross-Sectional Study.
    Pediatr Diabetes. 2024;2024:6701192.
    >> Share

  76. ORON T, Cortez FJ, Shtaif B, Robinson PV, et al
    Detection of Islet Autoantibodies in Whole Blood by Antibody Detection by Agglutination-PCR (ADAP) Technology Is Sensitive and Suitable for General Population Screening Programs.
    Pediatr Diabetes. 2024;2024:4238394.
    >> Share

  77. GRASSO EA, Chiarelli F
    Type 1 Diabetes and Other Autoimmune Disorders in Children.
    Pediatr Diabetes. 2024;2024:5082064.
    >> Share

  78. QUINN LM, Narendran P, Bhavra K, Boardman F, et al
    Developing a General Population Screening Programme for Paediatric Type 1 Diabetes: Evidence from a Qualitative Study of the Perspectives and Attitudes of Parents.
    Pediatr Diabetes. 2024;2024:9927027.
    >> Share

  79. HASSAN SS, Musa SA, De Franco E, Donis Frew R, et al
    Incidence, Phenotypes, and Genotypes of Neonatal Diabetes: A 16-Year Experience. The Rare Genetic Etiologies of Neonatal Diabetes Are Common in Sudan.
    Pediatr Diabetes. 2024;2024:2032425.
    >> Share

  80. ALISSA N, Alhumaidi S, Alzaid S, Aldibasi O, et al
    The Impact of Expanding Diabetes Services on the Trend of Glycemic Control in Children and Adolescents with Type 1 Diabetes.
    Pediatr Diabetes. 2024;2024:5529674.
    >> Share

  81. LAI CW, Craven M, Hershey JA, Lipman TH, et al
    Adverse Social Determinants of Health in Children with Newly Diagnosed Type 1 Diabetes: A Potential Role for Community Health Workers.
    Pediatr Diabetes. 2024;2024:8810609.
    >> Share

  82. ROSS K, Kulkarni K, MacDonald T, Pinto T, et al
    Assessing Risk Classification in Medication-Induced Diabetes during Induction Therapy in Pediatric Acute Lymphoblastic Leukemia.
    Pediatr Diabetes. 2023;2023:1057639.
    >> Share

  83. KYRONNIEMI A, Valtanen T, Koskenniemi J, Vahasalo P, et al
    Extremely Early Appearance of Islet Autoantibodies in Genetically Susceptible Children.
    Pediatr Diabetes. 2023;2023:9973135.
    >> Share

  84. FISHER EL, Weaver NA, Marlow AL, King BR, et al
    Macronutrient Intake in Children and Adolescents with Type 1 Diabetes and Its Association with Glycemic Outcomes.
    Pediatr Diabetes. 2023;2023:7102890.
    >> Share

  85. GRUBER N, Brand L, Barhod E, Hemi R, et al
    The Effect of COVID-19 on Type 1 Diabetes Occurrence among Children and Adolescents: A Multicenter Prospective Observational Cohort Study in Israel.
    Pediatr Diabetes. 2023;2023:6659719.
    >> Share

  86. PATEL TJ, Ayub A, Bone JN, Hadjiyannakis S, et al
    Incidence Trends of Type 2 Diabetes Mellitus, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children, Then (2006-2008) and Now (2017-2019).
    Pediatr Diabetes. 2023;2023:5511049.
    >> Share

  87. CRAIN ER, Ramphul R, Butler AM, Huang X, et al
    Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes.
    Pediatr Diabetes. 2023;2023:4751595.
    >> Share

  88. HEGAB AM, Hasaballah SE, Mohamed MM
    Splitting Mealtime Insulin Doses for Mixed Fat and Protein Meals in Children and Adolescents with Type 1 Diabetes Using Multiple Daily Injection Regimen: A Randomized Cross-Over Trial.
    Pediatr Diabetes. 2023;2023:7467652.
    >> Share

  89. MILLER KM, Bauza C, Kanapka LG, Clements MA, et al
    Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results.
    Pediatr Diabetes. 2023;2023:6718115.
    >> Share

  90. NATH MC, Frey B, Atchison J, Schmitt JA, et al
    Disparities in Glycemic Outcomes Persist in Youth with Type 1 Diabetes and High-Technology Use.
    Pediatr Diabetes. 2023;2023:6646582.
    >> Share

  91. MESSAAOUI A, Tenoutasse S, Hajselova L, Crenier L, et al
    Hypoglycemia Awareness Trajectories in Young People with Type 1 Diabetes Using Flash Glucose Monitoring.
    Pediatr Diabetes. 2023;2023:4882902.
    >> Share

  92. DEL VALLE ROLON ME, Brown EA, Wolf RM
    Real-World Glycemic Improvements with Hybrid Closed Loop Pumps in Youth with Type 1 Diabetes.
    Pediatr Diabetes. 2023;2023:6621706.
    >> Share

  93. HORVATH MD, Papp-Zipernovszky O, Tesch Z, Buzas N, et al
    Exploring Teachers' Attitudes toward the Management of Type 1 Diabetes: A Qualitative Study.
    Pediatr Diabetes. 2023;2023:6607310.
    >> Share

  94. LEUNG JMWS, Al-Yahyawi NY, Choi HS, Stewart LL, et al
    Diabetes Distress and Transition Readiness in Youths with Type 1 Diabetes Transitioning from Pediatric to Adult Care.
    Pediatr Diabetes. 2023;2023:5580180.
    >> Share

  95. JESPERSEN LN, Andersen TH, Grabowski D
    Comprehensive Overview of Quality of Life Instruments Used in Studies of Children with Diabetes: A Systematic Mapping Review.
    Pediatr Diabetes. 2023;2023:8885973.
    >> Share

  96. POLLE OG, Delfosse A, Michoux N, Peeters F, et al
    Pancreas Imaging of Children with Type 1 Diabetes Reveals New Patterns and Correlations with Pancreatic Functions.
    Pediatr Diabetes. 2023;2023:3295812.
    >> Share

  97. NIGROVIC LE, Kuppermann N, Ghetti S, Schunk JE, et al
    Emergency Department Presentations of Diabetic Ketoacidosis in a Large Cohort of Children.
    Pediatr Diabetes. 2023;2023:6693226.
    >> Share

  98. MESSER LH, Bauza C, Miller KM, Clements MA, et al
    Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial.
    Pediatr Diabetes. 2023;2023:6906023.
    >> Share

  99. ZHOU Y, Elbalshy MM, Styles SE, Crocket H, et al
    Subsequent Device Usage and Caregiver Attitudes to Do-It-Yourself Real-Time Continuous Glucose Monitoring (DIY-rtCGM) among Children with Type 1 Diabetes 3 Months after Participation in a Randomized Controlled Trial.
    Pediatr Diabetes. 2023;2023:3435944.
    >> Share

  100. HARNOIS-LEBLANC S, McNealis V, Friedrich MG, Bigras JL, et al
    Vascular and Myocardial Structure and Function in Adolescents with Type 1 Diabetes: The CARDEA Study.
    Pediatr Diabetes. 2023;2023:8662038.
    >> Share

  101. BAHREMAN N, Dietrich MS, Jaser S, Akard Foster T, et al
    A Comparison of Depressive Symptom Presentation in Adolescent Type 1 Diabetes and Pediatric Primary Care Samples.
    Pediatr Diabetes. 2023;2023:5597133.
    >> Share

  102. NAGL K, Waldhor T, Hofer SE, Blauensteiner N, et al
    Ongoing Increase in Incidence of Diabetes in Austrian Children and Adolescents (1989-2021): Results from a Nationwide Registry.
    Pediatr Diabetes. 2023;2023:4616903.
    >> Share

  103. EVIN F, Tittel SR, Piccini B, Cardona-Hernandez R, et al
    Basal and Bolus Insulin Distribution According to Treatment Modality: Data from SWEET Diabetes Registry.
    Pediatr Diabetes. 2023;2023:8837506.
    >> Share

  104. PRAHALAD P, Lorman V, Wu Q, Razzaghi H, et al
    Impact of SARS-CoV-2 Infection on Disease Trajectory in Youth with T1D: An EHR-Based Cohort Study from the RECOVER Program.
    Pediatr Diabetes. 2023;2023:8798997.
    >> Share

  105. LIU Y, Dong G, Huang K, Hong Y, et al
    Metabolomics and Lipidomics Studies in Pediatric Type 1 Diabetes: Biomarker Discovery for the Early Diagnosis and Prognosis.
    Pediatr Diabetes. 2023;2023:6003102.
    >> Share

  106. PEMBERTON JS, Gupta A, Lau GM, Dickinson I, et al
    Integrating Physical Activity Strategies to Lower Hyperglycaemia in Structured Education Programmes for Children and Young People with Type 1 Diabetes Improves Glycaemic Control without Augmenting the Risk of Hypoglycaemia.
    Pediatr Diabetes. 2023;2023:2519368.
    >> Share

  107. AREEKAL SA, Khadilkar A, Goel P, Cole TJ, et al
    Longitudinal Height Growth in Children and Adolescents with Type-1 Diabetes Mellitus Compared to Controls in Pune, India.
    Pediatr Diabetes. 2023;2023:8813031.
    >> Share

  108. FAVEL K, Mammen C, Panagiotopoulos C
    Longitudinal Estimated Glomerular Filtration Rate Trajectories in Children with Type 1 Diabetes.
    Pediatr Diabetes. 2023;2023:6648920.
    >> Share

  109. HOOD KK, Polonsky WH, MacLeish SA, Levy CJ, et al
    Psychosocial Outcomes with the Omnipod(R) 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers.
    Pediatr Diabetes. 2023;2023:8867625.
    >> Share

  110. RAHBAEK MO, Jensen SD, Hansen KK, Sandbaek A, et al
    The Danish Version of the Problem Areas in Diabetes-Teen (PAID-T) Scale: Translation and Linguistic Validation.
    Pediatr Diabetes. 2023;2023:4655563.
    >> Share

  111. REDEL JM, Hornung L, Elder D, Nathan JD, et al
    Diabetes-Related Quality of Life Assessment in Children following Total Pancreatectomy with Islet Autotransplantation.
    Pediatr Diabetes. 2023;2023:2851620.
    >> Share

  112. PHU A, Lin T, Manfredo JA, Brown EA, et al
    Similar Perceptions on Continuous Glucose Monitor Use amongst Youth with Type 1 and Type 2 Diabetes.
    Pediatr Diabetes. 2023;2023:1979635.
    >> Share

  113. MADRID-VALERO JJ, Ware J, Allen JM, Boughton CK, et al
    Sleep Quality and Quantity in Caregivers of Children with Type 1 Diabetes Using Closed-Loop Insulin Delivery or a Sensor-Augmented Pump.
    Pediatr Diabetes. 2023;2023:7937007.
    >> Share

  114. CHOBOT A, Eckert AJ, Biester T, Corathers S, et al
    Psychological Care for Children and Adolescents with Diabetes and Patient Outcomes: Results from the International Pediatric Registry SWEET.
    Pediatr Diabetes. 2023;2023:8578231.
    >> Share

  115. KARAKUS KE, Sakarya S, Sassmann H, Yildirim R, et al
    Disparities in Responsibility Sharing and Gender Differences in Diabetes Care: Changes in Occupational Life of Parents of Children with Type 1 Diabetes.
    Pediatr Diabetes. 2023;2023:7166604.
    >> Share

  116. KAMRATH C, Eckert AJ, Holl RW, Rosenbauer J, et al
    Impact of the COVID-19 Pandemic on Children and Adolescents with New-Onset Type 1 Diabetes.
    Pediatr Diabetes. 2023;2023:7660985.
    >> Share

  117. BABINSKI M, Duperval R, Altenor K, von Oettingen J, et al
    Impact of Sleep and Activity on Glycemic Control and Quality of Life in Haitian Children and Youth with Type 1 Diabetes.
    Pediatr Diabetes. 2023;2023:4289288.
    >> Share

  118. ALASSAF A, Gharaibeh L, Ibrahim S, Alkhalaileh S, et al
    Effect on Glycemic Control of an Early Intensive Dietary Structured Education Program for Newly Diagnosed Children with Type 1 Diabetes in Jordan.
    Pediatr Diabetes. 2023;2023:7258136.
    >> Share

  119. LORENZ AN, Pyle L, Ha J, Sherman A, et al
    Predictive Value of 1-Hour Glucose Elevations during Oral Glucose Tolerance Testing for Cystic Fibrosis-Related Diabetes.
    Pediatr Diabetes. 2023;2023:4395556.
    >> Share

  120. MONZON AD, McDonough R, Cushing CC, Clements M, et al
    Examining the Relationship between Nighttime Glucose Values in Youth with Type 1 Diabetes and Parent Fear of Nighttime Hypoglycemia.
    Pediatr Diabetes. 2023;2023:9953662.
    >> Share

  121. ZUIJDWIJK C, Courtney J, Mitsakakis N, Hayawi L, et al
    Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting.
    Pediatr Diabetes. 2023;2023:5106107.
    >> Share

  122. BECK JK, Allen RA, Jeter KM, Fisher RS, et al
    Real-Time Continuous Glucose Monitoring Reduced Costly Diabetes-Related Events in Adolescents and Young Adults despite Lack of Short-Term Reduction in Hemoglobin A1c.
    Pediatr Diabetes. 2023;2023:5253515.
    >> Share

  123. RASMUSSEN VF, Rasmussen D, Thrysoe M, Karlsson P, et al
    Cranial Nerve Affection in Adolescents with Type 1 Diabetes Assessed by Corneal Confocal Microscopy, Smell and Taste Tests.
    Pediatr Diabetes. 2023;2023:2709361.
    >> Share

  124. HO HC, Lo FS, Lee JK, Tsai WY, et al
    Glycated Hemoglobin is a Significant Predictor of Femoral, but Not of Carotid or Popliteal, Intima-Media Thickness in Adolescents with Type 1 Diabetes: A Case-Series Study.
    Pediatr Diabetes. 2023;2023:6471597.
    >> Share

  125. ROSE S, Galland BC, Styles SE, Wiltshire EJ, et al
    Impact of 6 months' Use of Intermittently Scanned Continuous Glucose Monitoring on Habitual Sleep Patterns and Sleep Quality in Adolescents and Young Adults with Type 1 Diabetes and High-Risk HbA1c.
    Pediatr Diabetes. 2023;2023:1842008.
    >> Share

  126. CHINCHILLA P, Dovc K, Braune K, Addala A, et al
    Perceived Knowledge and Confidence for Providing Youth-Specific Type 1 Diabetes Exercise Recommendations amongst Pediatric Diabetes Healthcare Professionals: An International, Cross-Sectional, Online Survey.
    Pediatr Diabetes. 2023;2023:8462291.
    >> Share


    PLoS Med

  127. FERALDI A, Zarulli V, Buse K, Hawkes S, et al
    Sex-disaggregated data along the gendered health pathways: A review and analysis of global data on hypertension, diabetes, HIV, and AIDS.
    PLoS Med. 2025;22:e1004592.
    >> Share


    PLoS One

  128. ALAZWARI A, Tafakori L, Johnstone A, Abdollahian M, et al
    Modeling the number of new cases of childhood type 1 diabetes using Poisson regression and machine learning methods; a case study in Saudi Arabia.
    PLoS One. 2025;20:e0321480.
    >> Share


    Stroke

  129. SHEEHY S, Aparicio HJ, Xu NN, Lioutas VA, et al
    Gestational Diabetes and Risk of Stroke Among US Black Women.
    Stroke. 2025 May 1. doi: 10.1161/STROKEAHA.124.050517.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016